The Gujarat-based firm said the continuous flow platform offers significant advantages over conventional batch processes, including enhanced process safety, superior reproducibility, improved scalability, higher operational efficiency and a lower environmental footprint.
ETFA is a critical fluorinated building block and reagent used in the synthesis of a wide range of organic fluorine compounds, which find extensive applications in pharmaceuticals, life sciences and performance materials sectors.
The global addressable market for ETFA is estimated at approximately USD 500-600 million, the company said in a statement.
Anupam Rasayan Managing Director Anand Desai said the commercialisation of ETFA through the continuous flow chemistry platform represents a significant milestone in the company’s innovation journey.
“Innovation remains at the core of our growth strategy. We will continue to invest in cutting-edge process technologies, research capabilities, and sustainable manufacturing practices to create long-term value for our customers, stakeholders, and the industry at large,” Desai said in a statement.
Anupam Rasayan India Ltd is a leading specialty chemicals manufacturer focused on life science-related chemicals, including agrochemicals and pharmaceuticals.